Also looking forward to news on Giardiasis test & something I think that will be really big, a test for endometriosis. 1 in 10 women suffer from this, which can be very debilitating & affect fertility & QOL. Exploratory surgery to confirm diagnosis is not always ideal. PIQ have stated in a recent announcement work on biomarkers are almost completed.
There is increased interest & awareness of Endometriosis, including a working party instigated by the Australian Govt to increase awareness for GPs & Healthcare providers & develop an Action Plan:
We haven’t heard anything about the collaboration with Atturos & Prostate Insitu test & mass spectrometry recently, but looking like this Irish company out of Dublin University are on track for their test to be available on market for mid 2020.
While PromarkerD may be the perceived jewel in the crown for PIQ, there is a lot more in the pipeline that we should probably be keeping our eye on as Investors too.
Best Wishes All
PIQ Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)